Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate.

Djouadi F, Bonnefont JP, Thuillier L, Droin V, Khadom N, Munnich A, Bastin J.

Pediatr Res. 2003 Oct;54(4):446-51. Epub 2003 Jul 2.

PMID:
12840153
2.

Metabolic myopathies: the challenge of new treatments.

Angelini C, Semplicini C.

Curr Opin Pharmacol. 2010 Jun;10(3):338-45. doi: 10.1016/j.coph.2010.02.006. Epub 2010 Mar 29. Review.

PMID:
20356791
3.

PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.

Djouadi F, Bastin J.

J Inherit Metab Dis. 2008 Apr;31(2):217-25. doi: 10.1007/s10545-008-0844-7. Epub 2008 Apr 4. Review.

PMID:
18392740
4.

Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia.

Vianey-Saban C, Mousson B, Bertrand C, Stamm D, Dumoulin R, Zabot MT, Divry P, Floret D, Mathieu M.

Eur J Pediatr. 1993 Apr;152(4):334-8. Review.

PMID:
8482285
5.
6.

The impact of fatty acid oxidation on energy utilization: targets and therapy.

Bebernitz GR, Schuster HF.

Curr Pharm Des. 2002;8(14):1199-227. Review.

PMID:
12052217
7.

[New approaches for the treatment of metabolic myopathies].

LaforĂȘt P, Nicolino M, Eymard B.

Rev Neurol (Paris). 2007 Oct;163(10):930-5. Review. French.

PMID:
18033029

Supplemental Content

Support Center